Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cerus Corp (NASDAQ:CERS)

2.26
Delayed Data
As of May 24
 +0.01 / +0.44%
Today’s Change
2.19
Today|||52-Week Range
7.64
-48.05%
Year-to-Date
Biotech Movers: Cerus, Alexion, NantKwest
May 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.25
Today’s open2.32
Day’s range2.19 - 2.33
Volume4,380,803
Average volume (3 months)1,078,191
Market cap$311.8M
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)-1.64%
Earnings growth (this year)-0.54%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+14.76%
P/E ratioNM
Price/Sales11.28
Price/Book5.37

Competitors

 Today’s
change
Today’s
% change
RMTIRockwell Medical Inc+0.39+5.81%
SRDXSurModics Inc-0.28-1.19%
ELGXEndologix Inc+0.14+2.92%
ELOSSyneron Medical Ltd0.000.00%
Data as of 05/24/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$39.3M
Annual profit (last year)-$62.9M
Net profit margin-160.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
William Mariner Greenman
Vice President-Manufacturing &
Operations
Suzanne Margerum
Corporate headquarters
Concord, California

Forecasts